855675P

16:0 Lyso PC

Avanti Research^™ - A Croda Brand

• 동의어(들): 1-hexadecanoyl-sn-glycero-3-phosphocholine; PC(16:0/0:0)
• 실험식(Hill 표기법): C₂₄H₅₀NO₇P
• CAS Number: 17364-16-8
• Molecular Weight: 495.63
• MDL number: MFCD00036904
• UNSPSC 코드: 51191904
• NACRES: NA.25

속성

• 설명: 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine
• 분석: >99% (LPC; may contain up to 10% of the 2-LPC isomer, TLC)
• 양식: powder
• 포장: pkg of 1 × 1 g (855675P-1g); pkg of 1 × 200 mg (855675P-200mg); pkg of 1 × 25 mg (855675P-25mg); pkg of 1 × 500 mg (855675P-500mg)
• 제조업체/상표: Avanti Research^™ - A Croda Brand
• 배송 상태: dry ice
• 저장 온도: −20°C
• SMILES string: O[C@](COP([O-])(OCC[N+](C)(C)C)=O)([H])COC(CCCCCCCCCCCCCCC)=O
• InChI: 1S/C24H50NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24(27)30-21-23(26)22-32-33(28,29)31-20-19-25(2,3)4/h23,26H,5-22H2,1-4H3/t23-/m1/s1
• InChI key: ASWBNKHCZGQVJV-HSZRJFAPSA-N

설명

애플리케이션

• Microbubble-Mediated Drug Delivery: The role of 16:0 Lyso PC in the development of microbubble technologies for drug delivery systems emphasizes its potential in pharmaceutical formulations, enhancing the efficiency of targeted therapy applications, particularly in cancer treatment (Aron et al., 2019).


• Photodynamic Therapy for Glioma: Research involving 16:0 Lyso PC in the context of biohybrid systems for light-activatable treatments showcases its application in medical therapies, particularly for treating challenging conditions like glioma through photodynamic therapy, underlining its potential in enhancing clinical outcomes (Inglut et al., 2019).

포장

20 mL Clear Glass Screw Cap Vial (855675P-1g)

20 mL Clear Glass Screw Cap Vial (855675P-500mg)

5 mL Amber Glass Screw Cap Vial (855675P-200mg)

5 mL Amber Glass Screw Cap Vial (855675P-25mg)

법적 정보

Avanti Research is a trademark of Avanti Polar Lipids, LLC

안전성 정보

• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable